BioFan1 Wednesday, 04/28/21 01:16:02 PM Re: None Post # of 83 Johns Hopkins Medicine Researchers to Present Data on MyMD Pharmaceuticals’ Supera-CBD at the 3rd Annual Neuroimmunology Drug Development Summit BUSINESS WIRE 10:13 AM ET 4/28/2021 BALTIMORE--(BUSINESS WIRE)-- MyMD Pharmaceuticals, Inc.(MYMD) , a clinical stage pharmaceutical company committed to extending healthy lifespan by focusing on developing two therapeutic platforms, announced today that researchers from the Johns Hopkins University School of Medicine will present the results of new research on the company’s compound Supera-CBD at the 3rd Annual Neuroimmunology Drug Development Summit. The poster presentation will discuss the preclinical cannabidiol (CBD) derivative that targets endogenous cannabinoid receptor type 2 for the treatment of psychiatric disorders. The researchers studied the compound in depression and anxiety-related phenotypes in mice. “This presentation of preclinical research will highlight the potential of Supera-CBD to address unmet needs in psychiatry," said Adam Kaplin, M.D., Ph.D., Chief Scientific Officer of MyMD Pharmaceuticals(MYMD). Researchers Chantelle Terrillion, Ph.D., Instructor in Neuroscience, and Anupama Kumar, MBBS, Research Associate in Psychiatry and primary investigator on the study, will present findings from preclinical studies on the role of Supera-CBD. Early findings revealed Supera-CBD’s potent anxiolytic properties. The data being presented at the conference also demonstrate that Supera-CBD binds to CB2 with almost four-times the affinity of CBD. Other research has shown that binding to CB2 potentially mediates a number of the therapeutic effects of CBD, including its anxiolytic, antinociceptive, anticonvulsant, antipsychotic, neuroprotective and anti-inflammatory effects. Details of the poster presentation are as follows: Title: Supera-CBD: A Novel CBD Derived Drug Candidate Abstract Number: 1858 Date and Time: April 28, 2021 at 4:15 p.m. ET. Access to Poster: The poster will be available at the conference website’s media library as well as on MyMD.com/pipeline/supera-cbdafter the time noted above.